检索结果 - David H. Gültekin

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Multiparametric Prostate MR Imaging with T2-weighted, Diffusion-weighted, and Dynamic Contrast-enhanced Sequences: Are All Pulse Sequences Necessary to Detect Locally Recurrent Prostate Cancer after Radiation Therapy?

    Multiparametric Prostate MR Imaging with T2-weighted, Diffusion-weighted, and Dynamic Contrast-enhanced Sequences: Are All Pulse Sequences Necessary to Detect Locally Recurrent Pro... 由 Olivio F. Donati, Sung Il Jung, Hebert Alberto Vargas, David H. Gültekin, Junting Zheng, Chaya S. Moskowitz, Hedvig Hricak, Michael J. Zeléfsky, Oğuz Akın

    出版 2013
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Incremental value of diffusion weighted and dynamic contrast enhanced MRI in the detection of locally recurrent prostate cancer after radiation treatment: preliminary results

    Incremental value of diffusion weighted and dynamic contrast enhanced MRI in the detection of locally recurrent prostate cancer after radiation treatment: preliminary results 由 Oğuz Akın, David H. Gültekin, Hebert Alberto Vargas, Junting Zheng, Chaya S. Moskowitz, Xin Pei, Dahlia Sperling, Lawrence H. Schwartz, Hedvig Hricak, Michael J. Zeléfsky

    出版 2011
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Treating Primary Liver Cancer with Hepatic Arterial Infusion of Floxuridine and Dexamethasone: Does the Addition of Systemic Bevacizumab Improve Results

    Treating Primary Liver Cancer with Hepatic Arterial Infusion of Floxuridine and Dexamethasone: Does the Addition of Systemic Bevacizumab Improve Results 由 Nancy E. Kemeny, Lawrence H. Schwartz, Mithat Gönen, Adam C. Yopp, David H. Gültekin, Michael I. D’Angelica, Yuman Fong, Dana Haviland, Alexandra N. Gewirtz, Peter J. Allen, William R. Jarnagin

    出版 2011
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival

    Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival 由 William R. Jarnagin, Lawrence H. Schwartz, David H. Gültekin, Mithat Gönen, Dana Haviland, Jinru Shia, M.I. D’Angelica, Yuman Fong, Ronald P. DeMatteo, Archie Tse, Leslie H. Blumgart, Nancy E. Kemeny

    出版 2009
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Antiangiogenic Therapy for Primary Liver Cancer: Correlation of Changes in Dynamic Contrast-Enhanced Magnetic Resonance Imaging with Tissue Hypoxia Markers and Clinical Response

    Antiangiogenic Therapy for Primary Liver Cancer: Correlation of Changes in Dynamic Contrast-Enhanced Magnetic Resonance Imaging with Tissue Hypoxia Markers and Clinical Response 由 Adam C. Yopp, Lawrence H. Schwartz, Nancy E. Kemeny, David H. Gültekin, Mithat Gönen, Zubin M. Bamboat, Jinru Shia, Dana Haviland, Michael I. D’Angelica, Yuman Fong, Ronald P. DeMatteo, Peter J. Allen, William R. Jarnagin

    出版 2011
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    Phase I Study of Intravenous Vascular Endothelial Growth Factor Trap, Aflibercept, in Patients With Advanced Solid Tumors

    Phase I Study of Intravenous Vascular Endothelial Growth Factor Trap, Aflibercept, in Patients With Advanced Solid Tumors 由 A. Craig Lockhart, Mace L. Rothenberg, Jakob Dupont, Wendy Cooper, Paul Chevalier, Lars Sternås, Giliane Buzenet, Elizabeth Koehler, Jeffrey A. Sosman, Lawrence H. Schwartz, David H. Gültekin, Jason A. Koutcher, Edwin F. Donnelly, Ric Andal, Isabelle Dancy, David R. Spriggs, William P. Tew

    出版 2009
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: